(Q24245420)

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

Haemopoietic response of Nigerian village children to iron, folate supplementation and malaria prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Mefloquine for preventing malaria in non-immune adult travellers.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Prevention versus treatment for malaria in pregnant women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Classification of clinical falciparum malaria and its use for the evaluation of chemosuppression in children under six years of age in Liberia, west Africa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

The influence of Maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of Mozambique.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

The effect of malaria suppression in a group of Accra school children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

The suppression of malarial parasitaemia by pyrimethamine in combination with dapsone or sulphormethoxine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Field trial of cycloguanil pamoate in the treatment and suppression of malaria in Nigerian school children: A preliminary report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Some effects of partial malaria suppression in Ugandan children during the first 3 years of life

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Susceptibility of Plasmodium falciparum in The Gambia to pyrimethamine, Maloprim and chloroquine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

A comparison of chloroquine and pyrimethamine as malaria chemoprophylactics in young Nigerian children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Double-blind study to assess the efficacy of chlorproguanil given alone or in combination with chloroquine for malaria chemoprophylaxis in an area with Plasmodium falciparum resistance to chloroquine, pyrimethamine and cycloguanil

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Immunity to malaria in young Gambian children after a two-year period of chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Cellular immune responses to Plasmodium falciparum antigens in children receiving long term anti-malarial chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

A comparative study of Lapudrine (chlorproguanil) and Maloprim (pyrimethamine and dapsone) as chemoprophylactics against malaria in Gambian children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Sustained protection against mortality and morbidity from malaria in rural Gambian children by chemoprophylaxis given by village health workers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Sensitivity of Plasmodium falciparum to chlorproguanil in Gambian children after five years of continuous chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Proguanil-sulphonamide for malaria prophylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

The cost-effectiveness of chemoprophylaxis with Maloprim administered by primary health care workers in preventing death from malaria amongst rural Gambian children aged less than five years old

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 6. The impact of the interventions on mortality and morbidity from malaria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 8. Cost-effectiveness of bed net impregnation alone or combined with chemoprophylaxis in preventing mortality and mo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Daily chlorproguanil is an effective alternative to daily proguanil in the prevention of Plasmodium falciparum malaria in Kenya

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Mortality and morbidity from malaria after stopping malaria chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

The effect of insecticide-treated bed nets on mortality of Gambian children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Vivax malaria resistant to treatment and prophylaxis with chloroquine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Hyperpigmented dermal macules in children following the administration of Maloprim for malaria chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Maloprim malaria prophylaxis in children living in a holoendemic village in north-eastern Tanzania

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Challenges in the development of antimalarial drugs with causal prophylactic activity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Effect of iron supplementation and malaria prophylaxis in infants on Plasmodium falciparum genotypes and multiplicity of infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Malaria chemoprophylaxis with tafenoquine: a randomised study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

"To search and Studdy out the secrett of Tropical Diseases by way of Experiment".

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Malaria intermittent preventive treatment in infants, chemoprophylaxis, and childhood vaccinations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Inadequacy of chlorproguanil 20 mg per week as chemoprophylaxis for falciparum malaria in Kenya

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Comparison of two strategies for control of malaria within a primary health care programme in the Gambia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Trimethoprim plus sulphamethoxazole compared with chloroquine in the treatment and suppression of malaria in African schoolchildren

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Malaria chemoprophylaxis with chloroquine in young Nigerian children. I. Its effect on mortality, morbidity and the prevalence of malaria.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Susceptibility of Plasmodium falciparum to chloroquine in northern Liberia after 20 years of chemosuppression and therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

The evidence base on the cost-effectiveness of malaria control measures in Africa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Cycloguanil pamoate in the treatment and suppression of malaria in the Gambia, West Africa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Comparison of mosquito nets, proguanil hydrochloride, and placebo to prevent malaria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Systematic reviews in health care: Assessing the quality of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Intermittent presumptive treatment for malaria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

A comparison of the antimalarial effects of suppressive doses of chloroquine, amodiaquin, and pyrimethamine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Malaria prophylaxis with proguanil in children living in a malaria-endemic area

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

A controlled trial of lambda-cyhalothrin-impregnated bed nets and/or dapsone/pyrimethamine for malaria control in Sierra Leone.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021

Randomized intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003756.PUB2

7 January 2021